Ipamorelin 5mg + Tesamorelin 5mg Peptides
Elevate your protocol with a clean, focused peptide blend engineered for precise, disciplined research.
This Ipamorelin + Tesamorelin lyophilized vial is a laboratory-grade peptide formulation designed for controlled studies. Format: lyophilized vial. Style: unflavored/unadulterated. Active ingredient type: growth hormone secretagogue research peptides. Total strength: 10mg per vial (5mg Ipamorelin + 5mg Tesamorelin). Produced for researchers who prioritize consistency, traceability, and methodical handling.
- 5mg Ipamorelin – A selective ghrelin receptor agonist studied for its precise, short-duration GH pulse dynamics and receptor specificity in preclinical models, supporting tightly controlled assay design.
- 5mg Tesamorelin – A synthetic growth hormone-releasing factor analog investigated for evaluating pituitary GH release and downstream IGF-axis signaling in well-structured in vitro and exploratory studies.
As a non-edible, laboratory-only material, this lyophilized peptide blend is intended for reconstitution according to internal SOPs. The powder format supports measured preparation and clear solution development, enabling repeatable dilutions and consistent experimental setup. Researchers value this presentation for comparative analysis, method development, and protocol refinement where uniform handling and reliable lot-to-lot performance are critical.
Ingredients: Ipamorelin, Tesamorelin (lyophilized peptides).
Peptide Scientific Labs operates with a quality-first mindset grounded in scientific discipline. Each lot is produced in the USA under stringent quality systems and released only after analytical verification for identity and purity. Lot-level documentation and traceability support audit-ready recordkeeping, while careful material handling and protective packaging help preserve integrity from our facility to your laboratory.
Trust is built through transparency and standards that do not bend. We emphasize clean composition, rigorous testing practices, and meticulous presentation so researchers can focus on data with confidence. If your work depends on consistency and clarity, this Ipamorelin + Tesamorelin vial provides a dependable foundation.
For laboratory research use only. Not for human consumption, medical, veterinary, or diagnostic use. Handle with appropriate PPE and aseptic technique per your institution’s SOPs.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
